Abstract:On the basis of the structures of small-molecule hits targeting the HIV-1 gp41, N-(4-carboxy-3-hydroxy)phenyl-2,5-dimethylpyrrole (2, NB-2), and N-(3-carboxy-4-chloro)phenylpyrrole (A(1), NB-64), 42 N-carboxyphenylpyrrole derivatives in two categories (A and B series) were designed and synthesized. We found that 11 compounds exhibited promising anti-HIV-1 activity at micromolar level and their antiviral activity was correlated with their inhibitory activity on gp41 six-helix bundle formation, suggesting that these compounds block HIV fusion and entry by disrupting gp41 core formation. The structure-activity relationship and molecular docking analysis revealed that the carboxyl group could interact with either Arg579 or Lys574 to form salt bridges and two methyl groups on the pyrrole ring were favorable for interaction with the residues in gp41 pocket. The most active compound, N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrrole (A(12)), partially occupied the deep hydrophobic pocket, suggesting that enlarging the molecular size of A(12) could improve its binding affinity and anti-HIV-1 activity for further development as a small-molecule HIV fusion and entry inhibitor.

ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

ChemInform Abstract: Design, Synthesis and Anti‐hiv Integrase Evaluation of 1,2,3‐triazol‐4‐yl‐substituted 1,4‐dihydro‐4‐oxo‐1,5‐naphthyridine‐3‐carboxylic Acids.

ChemInform Abstract: Improved Synthesis of 1‐[hexahydrocyclopenta [C]pyrrol‐2(1h)‐yl]‐3‐(4‐methylbenzenesulfonyl)urea.

ChemInform Abstract: Synthesis and Anti‐hiv Activity Evaluation of Novel 2,4‐disubstituted 7‐Methyl‐1,1,3‐trioxo‐2,4‐dihydro‐pyrazolo[4,5‐e][1,2]thiadiazines.

ChemInform Abstract: Synthesis and Anti‐hiv Activity Evaluation of 2‐(4‐(naphthalen‐2‐yl)‐1,2,3‐thiadiazol‐5‐ylthio)‐n‐acetamides As Novel Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors.

ChemInform Abstract: Synthesis and HIV‐1 Integrase Inhibition Activity of Some N‐Arylindoles.

Design, Synthesis, and Biological Evaluation of N-Carboxyphenylpyrrole Derivatives As Potent HIV Fusion Inhibitors Targeting Gp41

Design, Synthesis and Biological Evaluations of Novel Oxindoles As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1.

ChemInform Abstract: Synthesis and Biological Evaluation of Novel N‐[3‐(4‐phenylpiperazin‐1‐yl)‐propyl]‐carboxamide Derivatives.

ChemInform Abstract: Efficient Synthesis of a New Pyrimidine Derivative.

ChemInform Abstract: Synthesis and Antiviral Activities of Chiral Thiourea Derivatives.

ChemInform Abstract: Synthesis and Biological Evaluation of Novel Isopropanolamine Derivatives As Non‐Peptide Human Immunodeficiency Virus Protease Inhibitors.

4‐Aminopyrimidines As Novel HIV‐1 Inhibitors.

ChemInform Abstract: Anti Human Immunodeficieny Virus‐1 (HIV‐1) Agents. Part 1. Discovery of Benzyl Phenyl Ethers As New HIV‐1 Inhibitors in Vitro.

ChemInform Abstract: Anti-Human Immunodeficiency Virus-1 (HIV-1) Agents. Part 3. Synthesis and in Vitro Anti-Hiv-1 Activity of Some N-Arylsulfonylindoles.

Small molecule fusion inhibitors: design, synthesis and biological evaluation of (Z)-3-(5-(3-benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and related derivatives targeting HIV-1 gp41.

Design, Synthesis and Biological Evaluation of 3-Substituted 2,5-Dimethyl-n-(3-(1h-tetrazol-5-yl)phenyl)pyrroles As Novel Potential HIV-1 Gp41 Inhibitors

ChemInform Abstract: N‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea and N′‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐chloropyridyl)]‐thiourea As Potent Inhibitors of Multidrug‐Resistant Human Immunodeficiency Virus‐1.

Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41.

ChemInform Abstract: A Novel Synthesis of Thieno[2,3‐c]pyrazole.

ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.